The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team. Voprosy onkologii, v. 70, n. 3, p. 541–549, 4 Jul.2024.